I'm going to give you the science, the mechanisms and the practical protocols, because that's what you deserve
This process subsequently induces skin inflammation, the release of proinflammatory cytokines, and disruption of the skin barrier
#Diabetes #Obesity #GLP1 #HealthcareInnovation #Pharmaceuticals #CardiometabolicHealth To view or add a comment, sign in More Relevant Posts Eli Lilly and Company reported results from ACHIEVE-3, the first head-to-head #Phase3 trial evaluating the safety and efficacy of orforglipron, a small molecule oral GLP-1 without food or water restrictions, compared with oral semaglutide in adults with #Type2Diabetes
Key takeaways GLP-1 medications do not inherently cause muscle wasting. Most weight lost on semaglutide or tirzepatide is fat , not muscle. Some lean-mass loss during weight loss reflects adaptive remodeling , not pathology. Adequate protein intake and resistance training significantly reduce muscle loss during GLP-1 therapy. Do GLP-1 Medications Cause Muscle Wasting
Translational Considerations Several factors likely explain why vascular/anti-inflammatory effects in animals have not yielded MACE reductions in human trials
in these three solvents, an acid that is strong in DMSO (p K a,DMSO 0) is equally strong in these solvents